Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies to Raise A$5M in Direct Stock Offering

NEW YORK – Genomic testing firm Genetic Technologies said Friday that it had entered into definitive agreements with several investors for a registered direct stock offering that will raise A$5 million (US$3.5 million).

The investors agreed to buy 3,846,155 American Depositary Shares at A$1.30 per share. Each ADS represents 600 ordinary shares of the company. The offering is expected to close on Feb. 7, and H.C. Wainwright is acting as the exclusive placement agent.

The Australia-based firm said it plans to use some of the offering's proceeds to support its US and European commercialization of its GeneType Multi Risk test for cancers, coronary artery disease, and type 2 diabetes and to launch a comprehensive hereditary breast and ovarian cancer risk test. Other expenses funded by the offering include leveraging the firm's relationship with Qiagen to create new market opportunities, funding research and development, increasing sales and marketing efforts focused on consumer-initiated testing, and providing working capital and money for general corporate uses.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.